John Staffurth

9PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Data and information privacyApplications in health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial.

Paul Gravestock, Emma Clark, Miranda Morton

|Feb 25, 2023
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.

Ragu Ratnakumaran, Victoria Hinder, Douglas Brand

|May 27, 2021
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.

Douglas Adamson, Jane Blazeby, Catharine Porter

|Feb 26, 2021
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.

Martin John Connor, Taimur Tariq Shah, Katarzyna Smigielska

|Aug 11, 2020
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Freddie C Hamdy, Jenny L Donovan, J Athene Lane

|Dec 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol.

Emma Clark, Miranda Morton, Shriya Sharma

Pageof 2

Frequent Collaborators

2 joint publications

Rebecca Richards

2 joint publications

Paul Kinnersley

2 joint publications

Kate Brain

2 joint publications

Fiona Wood